# EDGAR Filing Document

**Accession Number:** 0001717847
**File Stem:** 0000094049-25-000007
**Filing Date:** 2025-11
**Character Count:** 9360
**Document Hash:** 21eea8ce3bc8111f6cbb96e0513f9124
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000094049-25-000007.hdr.sgml**: 20251110

**ACCESSION NUMBER**: 0000094049-25-000007

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251107

**FILED AS OF DATE**: 20251110

**DATE AS OF CHANGE**: 20251110

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Barry Andrea Jean
- **CENTRAL INDEX KEY:** 0001717847

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-04462
- **FILM NUMBER:** 251468113

**MAIL ADDRESS:**
- **STREET 1:** 7401 WEST WILSON AVENUE
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60706-4548
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STEPAN CO
- **CENTRAL INDEX KEY:** 0000094049
- **STANDARD INDUSTRIAL CLASSIFICATION:** SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 361823834
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** EDENS & WINNETKA ROAD
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093
- **BUSINESS PHONE:** 8474467500

**MAIL ADDRESS:**
- **STREET 1:** EDENS & WINNETKA ROAD
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STEPAN CHEMICAL CO /DE/
- **DATE OF NAME CHANGE:** 19840108

## Ex-24

```

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints each of Shawn G. Lisle, Kamel Aranki and James A. Hart, signing
singly, as the undersigned's true and lawful authorized representatives and
attorneys-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer of Stepan Company ("the Company"), Forms 3, 4 and 5, and any and
all amendments thereto, in accordance with Section 16 of the Securities
Exchange Act of 1934, as amended (the "1934 Act"), and the rules and
regulations promulgated thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such form or
schedule and the timely filing of such form or schedule with the United States
Securities and Exchange Commission and any stock exchange or stock market or
other authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorneys-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorneys-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorneys-in-fact may approve
in such attorneys-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorneys-in-fact,
or such attorneys-in-fact's substitute or substitutes, shall lawfully do or
cause to be done by virtue of this power of attorney and the rights and powers
herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming any of the
undersigned's responsibilities to comply with Section 16 or any other
provision of the 1934 Act.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 30th day of September, 2025.

/s/ Andrea J. Barry
Andrea J. Barry

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Barry Andrea Jean<br><sub>(Last) (First) (Middle)</sub><br>1101 SKOKIE BOULEVARD, SUITE 500<br><sub>(Street)</sub><br>NORTHBROOK, IL 60062<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-11-07 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_VP & CHRO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>STEPAN CO [ SCL ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2025-11-07 |  | A |  | 1159 |  | 2026-11-07<sup>(2)</sup> | 2028-11-07 | Restricted Stock Units | 1159 | $0 | 1159 | D |  |
| Stock Appreciation Right | $43.15 | 2025-11-07 |  | A |  | 1638 |  | 2026-11-07<sup>(2)</sup> | 2035-11-07 | Common Stock | 1638 | $0 | 1638 | D |  |
| Performance Shares | <sup>(3)</sup> | 2025-11-07 |  | A |  | 579 |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 579 | $0 | 579 | D |  |

---

### Footnotes:

(1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

(2) Vest ratably over three years beginning on the date shown.

(3) Each performance share represents a contingent right to receive one share of Stepan Company common stock.

(4) The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2027.

**Signature:** /s/ James A. Hart, attorney-in-fact for Andrea J. Barry  
**Date:** 2025-11-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**